Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Non-Penicillin Antibiotic Options for Non-Purulent Cellulitis

First-Line Non-Penicillin Options

  • The Infectious Diseases Society of America recommends clindamycin, trimethoprim-sulfamethoxazole (TMP-SMX), tetracyclines (doxycycline or minocycline), and linezolid as non-penicillin antibiotic options for outpatients with non-purulent cellulitis 1, 2
  • Clindamycin is effective against both β-hemolytic streptococci and community-acquired MRSA (CA-MRSA) 1
  • Tetracyclines, such as doxycycline or minocycline, are effective options, but have limited activity against β-hemolytic streptococci 1
  • Trimethoprim-Sulfamethoxazole (TMP-SMX) is effective against CA-MRSA, but has limited activity against β-hemolytic streptococci 1
  • Linezolid is effective against both β-hemolytic streptococci and MRSA 1

Treatment Duration

  • A 5-6 day course of antibiotic therapy is recommended for uncomplicated non-purulent cellulitis 2, 3
  • Treatment should be individualized based on clinical response 1

Special Considerations

  • Empirical coverage for CA-MRSA is recommended in patients who do not respond to β-lactam therapy 1
  • Consider MRSA coverage in patients with systemic toxicity 1
  • If coverage for both β-hemolytic streptococci and CA-MRSA is desired, options include clindamycin alone, TMP-SMX or a tetracycline in combination with a β-lactam, or linezolid alone 1

Inpatient Management

  • For hospitalized patients with non-purulent cellulitis, IV vancomycin, linezolid, daptomycin, telavancin, or clindamycin may be considered 4